PT - JOURNAL ARTICLE AU - Ben Ainsworth AU - Anne Bruton AU - Lucy Yardley AU - Mike Thomas TI - The development of my breathing matters: A digital intervention to improve patient self-management of asthma AID - 10.1183/13993003.congress-2016.PA734 DP - 2016 Sep 01 TA - European Respiratory Journal PG - PA734 VI - 48 IP - suppl 60 4099 - http://erj.ersjournals.com/content/48/suppl_60/PA734.short 4100 - http://erj.ersjournals.com/content/48/suppl_60/PA734.full SO - Eur Respir J2016 Sep 01; 48 AB - Background: It is estimated that appropriate early-intervention and self-management could prevent 70% of asthma-related hospital admissions. Patient education and self-management have been convincingly shown to improve clinical outcomes in asthma, and digital interventions have proved a cost-effective means by which to do this in other chronic health conditions. We used existing quantitative and a program of qualitative research to develop My Breathing Matters, an online self-management programme to improve a variety of asthma-related outcomes.Method: Our person-based approach to intervention development took an iterative approach, exploring patients' perceptions of My Breathing Matters using thematic analysis of in-depth think-aloud studies, with modifications based on feedback.Findings: The age range of the patient group was 21 to 61, all with a positive diagnosis of asthma. My Breathing Matters was viewed positively by patients as a tool for patient self-management. Patients had positive perceptions of both pharmacological and non-pharmacological self-management techniques. Patients approved of digital interventions for self-management, including personalized tailoring in order to allow quick access of relevant content (such as an online Personalized Asthma Action Plan).Conclusions: This study provides important evidence that digital interventions are an acceptable and well-liked way to improve asthma-related outcomes. Further research will conduct a feasibility trial of the intervention, with process analyses of patient and primary care staff experiences, to inform a future Phase 3 trial.